Elanco Animal Health (ELAN) Receivables - Other (2017 - 2026)

Elanco Animal Health has disclosed Receivables - Other across 10 years of filings, most recently posting $70.0 million for Q1 2026.

• Receivables - Other for Q1 2026 came in at $70.0 million, down 22.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $70.0 million (down 22.22% YoY), and the FY2025 annual result was $67.0 million, down 17.28% from the prior year.
• Receivables - Other came in at $70.0 million for Q1 2026 at Elanco Animal Health, up from $67.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $225.0 million in Q2 2023 to a low of $64.0 million in Q3 2024.
• The 5-year median for Receivables - Other is $114.0 million (2025), against an average of $142.8 million.
• Across the five-year window, Receivables - Other soared 110.58% in 2022 and tumbled 71.43% in 2024, its largest moves.
• Elanco Animal Health's Receivables - Other stood at $205.0 million in 2022, then dropped by 18.05% to $168.0 million in 2023, then tumbled by 51.79% to $81.0 million in 2024, then slipped by 17.28% to $67.0 million in 2025, then rose by 4.48% to $70.0 million in 2026.
• The last three Receivables - Other figures came in at $70.0 million (Q1 2026), $67.0 million (Q4 2025), and $81.0 million (Q3 2025), per Business Quant data.